MDS Podcast
Summary: The MDS Podcast channel was created with the ultimate goal of improving education in Parkinson's disease and other movement disorders, while keeping MDS members, other neurologists, health professionals and neuroscientists updated with novel and clinically-relevant research findings. A monthly issue of the podcast will highlight the results of an article published in the Society journals, Movement Disorders or Movement Disorders Clinical Practice, including an interview with one of the authors of the article selected.
- Visit Website
- RSS
- Artist: International Parkinson and Movement Disorder Society
- Copyright: Copyright 2022 MDS
Podcasts:
For the second episode of the special series focused on the peer review process, Dr. Prasad speaks with Dr. Deuschl about the crucial first part of the peer review process - identifying reviewers, and understanding when a reviewer should accept or decline an invitation to review.
Prof. Lozano shares the results of the phase 2 clinical trial showing safety and feasibility of the staged bilateral MR-guided focus ultrasound thalamotomy in 10 patients.
For the first episode of the special series focused on the peer review process, Dr. Di Luca speaks with Dr. Goetz about the importance and most important aspects of a peer review.
Dr. Hugo Morales discusses "Neuropsychiatric Features of Punding and Hobbyism in Parkinson's Disease," by Dr. Pedro Barbosa et al., from Movement Disorders Clinical Practice."
Dr. Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in Movement Disorders Clinical Practice on a "Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms."
Dr. Hoglinger discusses the article he recently published in the Movement Disorders Journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations.
Dr. Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today.
Dr. Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders Journal, highlighting the impact on several factors on the variability of movement disorders.
Dr. Matarazzo speaks with Prof. Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression.
The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD.
Dr. Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today.
Dr. Schaefer discusses with Dr. Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.
Dr. Schaefer speaks with Dr. Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease.
Dr. Schaefer speaks with Dr. Olvera about trending videos of tics and other neurological syndromes on social media.
Dr. Schaefer speaks with Dr. Camargo about the non-motor and prodromal features of dystonia.
